Bayer AG (CHIX:BAYND) Net Interest Margin (Bank Only) %


CHIX:BAYND Bayer AG CHIX:BAYND
56 GF Score
Price €51.57
GF Value €27.46
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CHIX:BAYND
56GF Score
Bayer AG CHIX:BAYND
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (CHIX:BAYND) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €51.57 is trading 87.8% above its estimated GF Value™ of €27.46. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for CHIX:BAYND:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €27.46 vs. price of €51.57 (87.8% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the CHIX:BAYND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
56GF Score

Get the complete analysis for CHIX:BAYND

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.57
Price
€27.46
GF Value